The DIA 2022 Global Annual Meeting is upon us! Next week peers from across the industry will gather to share ideas, learn from each other, network, and enjoy all that Chicago has to offer. This year the meeting is an in-person event and has thirteen different tracks providing learning opportunities for clinical trial professionals and clinical research teams.
The Opening Plenary: The Future of Healthcare sets the theme for the conference. Representatives from regulatory agencies, sponsors, academia, contract research, patient advocacy, and technology organizations will look to the future of healthcare. They will focus on patient-centricity, diversity & inclusion, digital healthcare, and the global nature of healthcare in the future. The variety of perspectives and the caliber of leaders included in this panel promise a rich discussion that will undoubtedly leave attendees with plenty of practical information for the present and visionary ideas for the future.
See the full agenda at https://www.diaglobal.org/en/flagship/dia-2022/.
In our annual preview, we are highlighting just a few of the sessions on our radar:
- #125 Patients as Influencers: How Today’s Patients are Shaping Tomorrow’s Clinical Trial Designs
Monday, June 20, 2:40 pm
Today’s data increasingly supports the notion that patients prefer to engage in clinical research when and where more digitally flexible options are made available to them and their loved ones. Study participants are actively shaping the design and functionality of clinical research – sharing their outcomes and data through multiple modern channels and platforms. As life science leaders, we must help drive momentum for these changes and enhance access for underrepresented patient groups. - #203: The Site Landscape: Data and Discussion of the State of the Clinical Research Site
Tuesday, June 21 at 9:00 am
Hear and learn from a panel of clinical research sites as they discuss data gathered from other sites all over the world. This data is critical to the continued success and sustainability of the clinical research sites - #204: Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity.
Tuesday, June 21 at 9:00 am
The session will focus on initiatives to enhance diversity and inclusion in clinical trials. Our panel of experts will discuss concrete strategies for achieving diversity and inclusion through community engagement, training, and educational campaigns - #336: Reviewing the FDA’s Guidance on PROs in Oncology Trials: How This Affects Future Measurement Strategy and Study Designs
Wednesday, June 22 at 12:45
In June ’21, FDA issued draft guidance on core PROs in cancer trials. This provides insight into regulatory thinking, and may lead to more future PRO-based labeling. This session explores how the guidance might affect study design and PRO selection.
The conference will wrap up on Thursday, June 23rd with an FDA Town Hall session that allows attendees to hear from agency representatives about where they are focusing their efforts, their collaborations with other health authorities, and what they have planned for the coming year. This year, the session includes representatives from the FDA’s Center for Drug Evaluation (CDER), Center for Biologic Evaluation (CBER), and the Oncology Center of Excellence (OCE).
In addition to soaking in multiple perspectives collaborating toward innovation, the Mednet team will be exhibiting at booth #1223. Stop by to meet our team and learn about our comprehensive, flexible platform, iMednet. We look forward to seeing you in person in the Windy City!
